According to a new market research report, „Epigenetics Market by Product“ (Kit, Enzyme, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User ( Academic, CRO) – Global Forecast to 2022 „ , published by MarketsandMarkets ™, is expected to reach US $ 1.057 million by 2022 from an estimated USD 854.0 million in 2017, at a CAGR of 13.5% during the forecast period.
Do not miss out on business opportunities in Epigenetics Market . Speak to our analyst and gain crucial insights that will help your business grow:
https://www.marketsandmarkets.com/speaktoanalyst.asp?id=896
The decreasing sequencing costs and time, increasing in research activities to identify and develop inhibitors / drugs for various diseases, funding for epigenetics research, and rising prevalence of cancer.
Growing applications in Personalized Medicine and Targeted Therapy in Oncology is a growth opportunity for the Epigenetics market
According to a press release published by the Tufts Center for the Study of Drug Development in May 2015, biopharmaceutical companies have nearly doubled their R & D investments in personalized medicine over the last five years, and these investments are expected to increase by 33% over the next five years. This will further drive the use of epigenetics tools. A 2016 study performed to analyze the epigenetic modification of chronic lymphocytic leukemia (CLL) in the patient population in prognostic biomarkers and personalized therapies. This study was performed by CeMM Research Center for Molecular Medicine of the Austrian Academy of Science in collaboration with the University of Southampton and the Royal Bournemouth Hospital under the European BLUEPRINT project and the International Human Epigenome Consortium.
Browse and in-depth TOC on “ Epigenetics Market“
191 – Tables
37 – Figures
230 – Pages
View more detailed TOC @
https://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html
Among the Application Segments, Oncology Dominated the Global Epigenetics Market in 2016
Based on application, the oncology segment accounted for the largest share of the Epigenetics Market in 2016. The Epigenetics Market in 2016. The Epigenetics Market.
DNA Methylation Segment Dominates the Epigenetics Market, by Technology in 2016
On the basis of technology, the Epigenetics Market is segmented into DNA methylation, histone modifications, and other technologies (includes non-coding RNA and chromatin remodeling). The DNA methylation segment accounted for the largest share of the Global Epigenetics Market in 2016. The large share of this segment is attributed to the increasing incidence of cancer and the ability of this technique to study different types of cancer with quality outcomes.
North America dominates the Global Epigenetics Market in 2016
North America accounted for the largest share of the Epigenetics Market in 2016, followed by Europe. Increase in epigenetics research activities, high R & D spending, rising incidence of various diseases, and the presence of key players in the region are driving the growth of the Epigenetics Market in North America.
Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=896
The major players in the Global Epigenetics Market are Illumina (US), Thermo Fisher (US), Diagenode (Belgium), QIAGEN ( US), Merck Millipore (US), Abcam (UK), Active Motif (US), New England Biolabs (US), Agilent (US), Zymo Research (US), PerkinElmer (US), and Bio-Rad (US) ,
Browse Adjacent Markets @Biotechnology Market Research Reports & Consulting
About MarketsandMarkets ™
MarketsandMarkets ™ provides quantified B2B research on 30,000 high growth opportunities / threats 70% to 80% of worldwide companies‘ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets ™ for their painpoints around
Our 850 fulltime analyst and SMEs at MarketsandMarkets ™ are following the „Growth Engagement Model – GEM“. The GEM aims to identify new opportunities, identify the most important customers, write attack, avoid and defend strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets ™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets ™ is going to spend more than 10,000 companies this year for their revenue planning and help them make their innovations / disruptions early to the market.
MarketsandMarkets‘ flagship competitive intelligence and market research platform, ‚Knowledge Store‘, joins over 200,000 markets and entire value chains for the understanding of the marketplace.
Contact:
Mr. Shelly Singh
MarketsandMarkets ™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
United States: 1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/epigenetics-technologies-market.asp
Visit Our Website: https://www.marketsandmarkets.com